TROG Cancer Research
Members Login   CQMS Login


Primary sponsor: Australasian Gastro-Intestinal Trials Group (AGITG)
Collaborating groups: Trans Tasman Radiation Oncology Group (TROG); Canadian Clinical Trials Group (CCTG); European Organisation for Research & Treatment of Cancer (EORTC)


A randomised phase II/III trial of preoperative chemoradiotherapy versus preoperative chemotherapy for resectable gastric cancer.


The main aim of this international study is to investigate whether treatment with chemotherapy plus radiotherapy has a better outcome than chemotherapy alone in patients undergoing surgery for resectable gastric cancer.

Participating centres

Current participating centres (PDF)

Accrual target


Current accrual

Current accrual graph (PDF)

Expected date of accrual completion

31 December 2020

Trial chairperson

Professor Trevor Leong, Peter MacCallum Cancer Centre, VIC

Trial contact

Sarah York
Clinical Trial Coordinator
Phone: +61 2 9562 5316

Further information

TROG trial 08.08 on Australian Cancer Trials website

AGITG Website

Trial resources for TROG members

TROG 08.08 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.